Elevation of the adiponectin/leptin ratio in women with gestational diabetes mellitus after supplementation with alpha-lipoic acid

Hadise Aslfalah,Mehri Jamilian,Ali Khosrowbeygi

DOI: https://doi.org/10.1080/09513590.2018.1519795

2018-10-10

Gynecological Endocrinology

Abstract:Alpha-lipoic acid (ALA) is a short chain fatty acid and is known as a universal antioxidant. The aim of the current clinical trial study was to explore the effects of ALA supplementation on maternal circulating values of adiponectin (A), leptin (L); and A/L, L/A, adiponectin/homeostatic model assessment for insulin resistance (A/H), and malondialdehyde/total antioxidant capacity (MDA/TAC) ratios in pregnant women with gestational diabetes mellitus (GDM). Sixty women diagnosed as GDM during 24 and 28 weeks of pregnancy were randomly divided into drug (<i>n</i> = 30) and placebo (<i>n</i> = 30) groups. They consumed ALA (100 mg) and cellulose acetate (100 mg) respectively for 8 weeks, per day. The biochemical variables were evaluated before and after the trial. Maternal fasting serum values of glucose (<i>p</i> < .001), HOMA-IR (<i>p</i> < .001), MDA/TAC (<i>p</i> < .001), and L/A (<i>p</i> = .008) were decreased while values of adiponectin (<i>p</i> = .011), A/L (<i>p</i> = .001), and A/H (<i>p</i> < .001) were increased in the drug group after the intervention. In summary, current study had shown that after daily supplementation with 100 mg of ALA for 8 weeks in women with GDM, maternal circulating values of adiponectin, A/L, and A/H were increased while values of L/A and MDA/TAC were decreased.

endocrinology & metabolism,obstetrics & gynecology